Pacira BioSciences, Inc. Share Price

Pacira BioSciences, Inc. Share Price

NASDAQ: PCRX | Small Cap
$36.39
+$0.01 (0.01%) Last updated on 30 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Pacira BioSciences, Inc. Stock Performance

Open
$36.40
Prev. Close
$36.38
Circuit Range
N/A
Day Range
$36.37 - $36.40
Year Range
$18.83 - $36.66
Volume
35,501
Average Traded
$36.38

Pacira BioSciences, Inc. Share Price Today

As of 30 October 2026, Pacira BioSciences, Inc.'s share price is $36.39. The stock opened at $36.40, compared to its previous close of $36.38. During today's trading session, Pacira BioSciences, Inc.'s share price traded between $36.37 and $36.40, with an average price of $36.38. Over the past 52 weeks, the stock has recorded a high of $36.66 and a low of $18.83. In terms of performance, Pacira BioSciences, Inc.'s share price has risen by 42.65% over the last six months and is up 70.05% on a year-on-year basis.

Pacira BioSciences, Inc. Share Price Chart

Line chart of the Pacira BioSciences, Inc. price trend over the selected period. The price rose overall, ranging from 36.37 to 36.40, ending at 36.38.
$36.37$36.40
L
Show Current Price
H

Pacira BioSciences, Inc. Stock Fundamentals & Key Indicators

Market Cap
$1.62B
PE Ratio (TTM)
99.22
Dividend Yield
0.00%
EPS (TTM)
$0.37
Revenue (TTM)
$726.41B
Return On Equity (TTM)
2.18%
Profit Margin
0.97%
Debt to Equity
0.54
Quarterly Earnings Growth YoY
-14.36%

Pacira BioSciences, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$179.52$196.87$177.38$192.40
Net Profit$5.43$1.64$2.92$4.65
Net Profit Margin3.02%0.83%1.65%2.42%
Income ChangeN/A-69.80%78.05%59.25%

Pacira BioSciences, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$666.82$674.98$700.97$726.41
Net Profit$15.91$41.96-$99.56$7.03
Net Profit Margin2.39%6.22%-14.20%0.97%
Income ChangeN/A163.73%-337.27%107.06%

About Pacira BioSciences, Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Pacira BioSciences, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$25.09
$36.38
+45.15%
Sep 2026
$26.25
$25.06
-2.98%
Aug 2026
$26.34
$25.83
-2.33%
Jul 2026
$25.70
$26.45
+4.24%
Jun 2026
$23.10
$25.37
+9.09%
May 2026
$26.29
$23.25
-8.84%
Apr 2026
$22.34
$25.51
+12.88%
Mar 2026
$21.61
$22.60
+3.10%
Feb 2026
$20.60
$21.92
+6.67%
Jan 2026
$26.23
$20.55
-20.55%
Dec 2025
$23.67
$25.86
+9.32%
Nov 2025
$21.37
$23.66
+10.56%

PCRX Share Price FAQs